About the Company
armaForce Inc., a privately held Columbus, Ohio based pharmaceutical R&D and manufacturing company, was founded in 1999. PharmaForce began as a small team R&D outfit, but quickly expanded to include manufacturing capabilities. In 2009, Luitpold Pharmaceuticals, Inc., a New York based U.S. Company of Daiichi-Sankyo Co., Ltd. (Corporate Headquarters: Tokyo, Japan), acquired PharmaForce. This acquisition allowed for the expansio...
armaForce Inc., a privately held Columbus, Ohio based pharmaceutical R&D and manufacturing company, was founded in 1999. PharmaForce began as a small team R&D outfit, but quickly expanded to include manufacturing capabilities. In 2009, Luitpold Pharmaceuticals, Inc., a New York based U.S. Company of Daiichi-Sankyo Co., Ltd. (Corporate Headquarters: Tokyo, Japan), acquired PharmaForce. This acquisition allowed for the expansion of the R&D pipeline, increased manufacturing capacity, and an ability to develop a robust pipeline in the fast growing generic injectable market. Today, PharmaForce’s experienced R&D team coupled with state-of-the-art manufacturing capabilities has allowed for a turnkey, complete pharmaceutical operation.
Facilities
PharmaForce, Inc., headquartered in Columbus, Ohio, operates out of three facilities. The first facility, constructed in 2005, is a 20,000 sq. ft. facility located near Worthington, OH that is now home to our Quality Control and Microbiology teams. Then, in 2007, another 20,000 sq. ft. site was built in Hilliard, OH designed for parenteral and ophthalmic manufacturing. Most recently in 2011, the state-of-the-art 109,000 sq. ft. corporate headquarters was established in New Albany, OH that consists of 15,000 sq. ft. of laboratories dedicated to Research and Development, a 13,000 sq. ft administration area, and a 72,000 sq. ft. manufacturing plant.